Shares

CMS Proposed Rule Reduces Drug Payments & Requires Implementation of Value-Based Purchasing Tools
Recently, CMS published a Proposed Rule seeking to test a new model for how Medicare pays for drugs and biologicals paid under the Medicare Part B program. With the goals of determining whether alternative drug payment models will result in “better care” and “smarter spending” by reducing Medicare expenditures while enhancing the quality of care, CMS proposed a two phase Part B Drug Payment Model to “test whether alternative payment approaches for Part B drugs improve value (relative to current drug payment approaches under Part B).”
Read More On www.healthcarelawtoday.comCategories HIE policies & guidelines Payment Models & Reimbursement